Researchers at the University of Kentucky College of Medicine found that one group of antibiotics
Frontotemporal dementia usually beginsdevelop between the ages of 40 and 65 and is the second most common after Alzheimer's disease. Some patients with frontotemporal dementia have a special genetic mutation, due to which brain cells cannot produce progranulin protein. Because of this, according to the researchers, the disease develops.
During the experiments, scientists saw that whenusing aminoglycoside antibiotics, neurons with such a mutation begin to synthesize this protein. Researchers injected drug molecules into cells and observed the effect. This finding may help in the further development of anti-dementia drugs.